Science Applications International ( NASDAQ: SAIC ) secured a $112.3M Navy contract modification linked to the MK 48 Heavyweight Torpedo program. The contract covers production, spare parts, production support materials, engineering support, and hardware repairs for the MK 48 MOD 7 Heavyweight Torpedo system. The deal mainly supports the U.S. Navy (99%), while the remaining 1% is for the Royal Aus...
Science Applications International ( NASDAQ: SAIC ) secured a $112.3M Navy contract modification linked to the MK 48 Heavyweight Torpedo program. The contract covers production, spare parts, production support materials, engineering support, and hardware repairs for the MK 48 MOD 7 Heavyweight Torpedo system. The deal mainly supports the U.S. Navy (99%), while the remaining 1% is for the Royal Australian Navy through the FMS program. The work is expected to be completed by April 2029. Funding includes $94.8M from FY25, $12.8M from FY26, $1.9M from FY24 Navy funds, and $918K from foreign partners, out of which $1.9M will expire by the end of the current fiscal year. The Naval Sea Systems Command is the contracting activity. More on Science Applications Science Applications International Corporation (SAIC) Q4 2026 Earnings Call Transcript Science Applications International Corporation 2026 Q4 - Results - Earnings Call Presentation USAID shutdown fallout ripples through Washington economy SAIC targets $7B–$7.2B revenue in FY '27 while advancing portfolio focus and margin expansion Seeking Alpha’s Quant Rating on Science Applications
The pitch for the YieldMax COIN Option Income Strategy ETF (NYSEARCA:CONY) is a distribution yield quoted anywhere from 60% to 120% annualized, paid weekly, all derived from selling options on Coinbase (NASDAQ:COIN) shares. Investors hunting income see CONY and assume they’ve found a money-spinning miracle attached to crypto’s most prominent equity. The reality since its August 2023 ... CONY’s Dre...
The pitch for the YieldMax COIN Option Income Strategy ETF (NYSEARCA:CONY) is a distribution yield quoted anywhere from 60% to 120% annualized, paid weekly, all derived from selling options on Coinbase (NASDAQ:COIN) shares. Investors hunting income see CONY and assume they’ve found a money-spinning miracle attached to crypto’s most prominent equity. The reality since its August 2023 ... CONY’s Dreamy Yield Hides a Track Record That Should Concern Long Term Holders
US Secretary of State Marco Rubio voiced hope on Thursday of progress on ending the war with Iran, with mediator Pakistan’s army chief due to arrive in the Islamic republic for talks. The expected visit by Field Marshal Asim Munir, a powerful figure with a growing role in Pakistan’s foreign relations, comes a day after US President Donald Trump warned that negotiations to end the war were on the “...
US Secretary of State Marco Rubio voiced hope on Thursday of progress on ending the war with Iran, with mediator Pakistan’s army chief due to arrive in the Islamic republic for talks. The expected visit by Field Marshal Asim Munir, a powerful figure with a growing role in Pakistan’s foreign relations, comes a day after US President Donald Trump warned that negotiations to end the war were on the “borderline” between a deal and renewed strikes. “I believe the Pakistanis will be travelling to Tehran today. So hopefully that’ll advance this further,” Rubio told reporters on Thursday. Advertisement A ceasefire on April 8 halted the war launched weeks earlier by the US and Israel, but negotiation efforts have so far failed to yield a lasting peace agreement. A war of words has taken the place of open conflict but the impasse continues to weigh on the world economy, leaving everyone from investors to farmers in a painful state of uncertainty. Advertisement On Thursday, Iran’s ISNA news agency said Munir’s visit was aimed at continuing “talks and consultations” with Iranian authorities, without providing details. Other Iranian media carried the same report.
Investors seeking to capitalize on the dominance of U.S. growth stocks have two primary options within the Vanguard lineup. While both the Vanguard Mega Cap Growth ETF (MGK +0.14%) and the Vanguard Russell 1000 Growth ETF (VONG +0.02%) prioritize companies with strong earnings potential, they differ significantly in how far down the market-cap ladder they reach to build their portfolios. Here’s ho...
Investors seeking to capitalize on the dominance of U.S. growth stocks have two primary options within the Vanguard lineup. While both the Vanguard Mega Cap Growth ETF (MGK +0.14%) and the Vanguard Russell 1000 Growth ETF (VONG +0.02%) prioritize companies with strong earnings potential, they differ significantly in how far down the market-cap ladder they reach to build their portfolios. Here’s how the two stack up on the most important factors. Snapshot (cost & size) Metric MGK VONG Issuer Vanguard Vanguard Expense ratio 0.05% 0.06% 1-yr return (as of May 21, 2026) 28.86% 25.41% Dividend yield 0.34% 0.45% Beta (5Y monthly) 1.20 1.15 Assets under management (AUM) $32.0 billion $50.6 billion MGK is the more affordable of the two options, carrying a marginally lower expense ratio. VONG, however, offers a slightly higher dividend yield, which could help counteract the higher fees. Performance & risk comparison Metric MGK VONG Max drawdown (5 yr) -36.02% -32.72% Growth of $1,000 over 5 years (total return) $2,110 $2,040 What's inside VONG provides exposure to 387 holdings, offering broader exposure to the large-cap growth space. Its sector allocation is heavily weighted toward technology, accounting for around 51% of assets, followed by communication services at 13% and consumer cyclical at 13%, and its largest positions include Nvidia, Apple, and Microsoft. Launched in 2010, the fund seeks to track the Russell 1000 Growth Index and has a trailing 12-month dividend of $0.56 per share. By comparison, MGK tracks the CRSP US Mega Cap Growth Index and focuses exclusively on the largest tier of the growth market, resulting in a tighter portfolio of just 59 holdings. Its sector allocation tilts even more aggressively toward technology at around 56% of assets, while allocating around 18% to communication services and 13% to consumer cyclical. Its top holdings match VONG’s, and it offers a trailing-12-month dividend of $0.29 per share. For more guidance on ETF investing, check ...
Keir Starmer’s UK election landslide in 2024 came after a series of Conservative governments marked by scandal, chaos and a budget problem with no easy fix. Two years later, the Labour prime minister finds himself on the other end of the equation, with unemployment up and his approval down as rivals line up to replace him at 10 Downing Street. But even if Starmer falls, the same intractable financ...
Keir Starmer’s UK election landslide in 2024 came after a series of Conservative governments marked by scandal, chaos and a budget problem with no easy fix. Two years later, the Labour prime minister finds himself on the other end of the equation, with unemployment up and his approval down as rivals line up to replace him at 10 Downing Street. But even if Starmer falls, the same intractable financial problems await his replacement — in particular a very unforgiving bond market. On this weekly documentary from Bloomberg Originals , we explain the economic reality facing Britain and why it’s so hard to change. Starmer’s position has been looking increasingly precarious following recent losses in local elections. The lack of economic growth, rising inflation, tax increases and even a Jeffrey Epstein-related scandal all combined to make him increasingly vulnerable. But among his larger problems is the cost of servicing UK debt. Long-term government borrowing had been falling, but in recent times has risen to its highest level since 1998. The more the government has to pay in interest, the less it can spend on what voters want. With taxes already high and a pressing need for spending on defense and services, Starmer — and his replacement should they come — will have very few choices. To see more Bloomberg Originals video documentaries, click here . See the latest videos from Bloomberg Originals here .
(RTTNews) - Spotify has teamed up with Universal Music Group to let users make AI-generated covers and remixes from songs by artists involved in the program. This partnership is a big move for the music industry, representing one of the largest commercial agreements on AI licensing to date. The new feature will be available as a paid add-on for Spotify Premium users, and it will include a revenue-...
(RTTNews) - Spotify has teamed up with Universal Music Group to let users make AI-generated covers and remixes from songs by artists involved in the program. This partnership is a big move for the music industry, representing one of the largest commercial agreements on AI licensing to date. The new feature will be available as a paid add-on for Spotify Premium users, and it will include a revenue-sharing model for artists and songwriters whose music is incorporated into these AI creations. However, Spotify hasn't revealed any pricing information or when it plans to launch this feature. Alex Norström, Co-Chief Executive Officer, mentioned that the focus is on building tools that respect "consent, credit, and compensation." He stressed that the artists will have the final say over how their music is utilized. Lucian Grainge pointed out that this partnership could help artists engage more with their fans and create new ways to earn money through generative AI. This agreement comes at a time when the music industry is grappling with AI copyright challenges. Companies like Suno and Udio have faced lawsuits from major record labels for allegedly using copyrighted music to train their AI systems without permission. Spotify's strategy is different; they're securing licensing deals with music labels before launching any AI products for consumers. The company has hinted that more partnerships with labels might be in the works as interest in AI music tools increases. The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
Workday Inc. , a maker of workplace management software, posted better-than-expected results in the first quarter, helping quell concerns that the company will be disrupted by artificial intelligence. Sales rose 13% to $2.54 billion in the period, Workday said in a statement Thursday. Analysts had projected $2.52 billion. Earnings, which climbed to $2.66 a share when excluding some items, also top...
Workday Inc. , a maker of workplace management software, posted better-than-expected results in the first quarter, helping quell concerns that the company will be disrupted by artificial intelligence. Sales rose 13% to $2.54 billion in the period, Workday said in a statement Thursday. Analysts had projected $2.52 billion. Earnings, which climbed to $2.66 a share when excluding some items, also topped predictions. Workday, whose software helps handle office duties such as payroll and human resources, has been working to weave AI into its products. It also recently shook up leadership. In February, the company announced that former Chief Executive Officer and co-founder Aneel Bhusri would return to run the company he had stepped back from in 2024. Read More: Workday Co-Founder Returns as CEO Amid Steep Share Decline Thursday’s report sent shares up roughly 10% in extended trading. They had lost about 43% of their value this year through the close, as investors questioned Workday’s ability to thrive in the AI era. “This should be viewed as a solid quarter and an encouraging first step under Aneel’s return as CEO,” said Kirk Materne , an analyst at Evercore ISI. The report “should help alleviate some of the near-term concerns around execution and demand durability.” The Pleasanton, California-based company also forecast subscription revenue for the second quarter that narrowly topped analysts’ estimates. “We had a great Q1, and it makes one thing clear: Workday is ready for this AI moment,” Bhusri said in the statement. “Our core business is strong, our AI strategy is working, and we’re moving with the speed and focus required to lead.”
The S&P 500 (SNPINDEX:^GSPC) edged up 0.17% to 7,445.72 after choppy oil‑driven trading, the Nasdaq Composite (NASDAQINDEX:^IXIC) added 0.09% to 26,293.10, and the Dow Jones Industrial Average (DJINDICES:^DJI) climbed 0.55% to 50,285.66, rebounding from early losses. Market movers Nvidia slipped from early strength despite yesterday’s blowout earnings. International Business Machines rallied over ...
The S&P 500 (SNPINDEX:^GSPC) edged up 0.17% to 7,445.72 after choppy oil‑driven trading, the Nasdaq Composite (NASDAQINDEX:^IXIC) added 0.09% to 26,293.10, and the Dow Jones Industrial Average (DJINDICES:^DJI) climbed 0.55% to 50,285.66, rebounding from early losses. Market movers Nvidia slipped from early strength despite yesterday’s blowout earnings. International Business Machines rallied over 12% on quantum computing developments. Walmart dropped 7% following its Q1 results, while rival Costco Wholesale slipped 2%. Spotify Technology soared after it wowed investors with its growth plans. What this means for investors U.S. markets inched higher today, erasing early losses, as oil prices fell on reports of progress in U.S.-Iran negotiations. It is becoming a familiar story as traders watch for headway on reopening the Strait of Hormuz, which would be the first step toward normalizing oil supplies. However, until a deal is done, investors can expect further volatility. Fears that elevated oil prices could fuel further inflation has lead to a surge in bond yields, and some argue this will start to pressure global equities. BCA Research, a Canadian investment analysis firm, think the outlook for stocks is weak right now, particularly because much of the recent rally was driven by a handful of artificial intelligence (AI) and semiconductor stocks. Meanwhile, anticipation is growing about mega-IPOs from SpaceX and OpenAI. Some traders expect their market caps to top $1 trillion when they go public, raising concerns that they could take capital from other large-cap names. Should you buy stock in S&P 500 Index right now? Before you buy stock in S&P 500 Index, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now… and S&P 500 Index wasn’t one of them. The 10 stocks that made the cut could produce monster returns in the coming years. Consider when Netflix made this list on December 17, 20...
Tripp Hornick, principal at Quince Street Strategy, said that the US allowed the mining and manufacturing of rare earth elements to be pushed overseas because investors felt it was too expensive and 'dirty' to back. Now, the US is facing the consequences of moving that supply chain process overseas, as the US and other world powers race to build a system that is not reliant on China for minerals t...
Tripp Hornick, principal at Quince Street Strategy, said that the US allowed the mining and manufacturing of rare earth elements to be pushed overseas because investors felt it was too expensive and 'dirty' to back. Now, the US is facing the consequences of moving that supply chain process overseas, as the US and other world powers race to build a system that is not reliant on China for minerals that are key to national security. (Source: Bloomberg)
Buzz Capital ( BUZ.P:CA ) on Thursday said it plans to conduct a non-brokered private placement of up to 6.67 million units at $0.15 per unit for gross proceeds of up to $1 million. Each unit will consist of one common share and one-half of a share purchase warrant, with each whole warrant exercisable at $0.35 per share for 24 months after issuance, the company said. Buzz Capital said proceeds fro...
Buzz Capital ( BUZ.P:CA ) on Thursday said it plans to conduct a non-brokered private placement of up to 6.67 million units at $0.15 per unit for gross proceeds of up to $1 million. Each unit will consist of one common share and one-half of a share purchase warrant, with each whole warrant exercisable at $0.35 per share for 24 months after issuance, the company said. Buzz Capital said proceeds from the offering will be used primarily to identify and evaluate potential acquisitions or businesses for a qualifying transaction, as well as for working capital purposes. The company added that the closing of the private placement is subject to TSX Venture Exchange acceptance, regulatory approvals, and completion of a change of management and control. Source: Press Release More on Buzz Capital Inc. Financial information for Buzz Capital Inc.
mF International ( MFI ) announced on Thursday that it has received written notification from Nasdaq, notifying the company that it is not in compliance with Nasdaq Listing Rule as it has not yet filed its annual report on Form 20-F for the year ended December 31, 2025. The notification letter has no immediate effect on the listing or trading of the company's class A ordinary shares on Nasdaq. In ...
mF International ( MFI ) announced on Thursday that it has received written notification from Nasdaq, notifying the company that it is not in compliance with Nasdaq Listing Rule as it has not yet filed its annual report on Form 20-F for the year ended December 31, 2025. The notification letter has no immediate effect on the listing or trading of the company's class A ordinary shares on Nasdaq. In accordance with Nasdaq's listing rules, the company has until July 17, 2026, to submit a plan of compliance to Nasdaq addressing how the Company intends to regain compliance with Nasdaq rules. The company said it is currently working with its accounting, audit, and legal professionals to prepare and submit the plan to Nasdaq and to prepare the Form 20- F. More on mF International Seeking Alpha’s Quant Rating on mF International Historical earnings data for mF International Financial information for mF International
Key Points Medicare doesn't currently cover GLP-1s for weight loss. A new program was supposed to change this, but it's been indefinitely postponed. The GLP-1 Bridge program, beginning in July 2026, has been extended through 2027. The $23,760 Social Security bonus most retirees completely overlook › GLP-1s are some of the most popular prescription medications today. Unfortunately, when it comes to...
Key Points Medicare doesn't currently cover GLP-1s for weight loss. A new program was supposed to change this, but it's been indefinitely postponed. The GLP-1 Bridge program, beginning in July 2026, has been extended through 2027. The $23,760 Social Security bonus most retirees completely overlook › GLP-1s are some of the most popular prescription medications today. Unfortunately, when it comes to them, many Americans still have to choose between their health and their pocketbooks. This includes Medicare beneficiaries, who currently only have their GLP-1s covered if they use the medications to treat an underlying condition, like type 2 diabetes. All that seemed about to change a few months ago, when the government promised a new program -- the Better Approaches to Lifestyle and Nutrition for Comprehensive hEalth (BALANCE) model -- that would cover GLP-1s for weight loss for Medicare beneficiaries. However, it's been tabled indefinitely. Will AI create the world's first trillionaire? Our team just released a report on the one little-known company, called an "Indispensable Monopoly" providing the critical technology Nvidia and Intel both need. Continue » The BALANCE model was originally scheduled to take effect in January 2027 and would have allowed Medicare Part D sponsors to decide whether to cover GLP-1s for weight loss. However, that plan has been delayed, with no indication of when it will now take effect. That doesn't mean Medicare beneficiaries are out of luck, though. There's a new Medicare GLP-1 Bridge program that will take effect in July 2026. This will enable Medicare beneficiaries to have their GLP-1s for weight loss covered by Medicare, as long as their healthcare provider submits a prior authorization request and a prescription for a covered medication. This program was initially only supposed to last through the end of the year, but the government has now extended it through 2027. It's unclear what will happen to it beyond this point. It's also worth n...
Daily Wire Names New CEO As Audience, Revenue Challenges Mount The Daily Wire announced Tuesday that CEO Caleb Robinson is stepping down effective immediately and transitioning to a board role while retaining significant ownership in the company. Mike Richards, who joined as President and Chief Content Officer roughly a year ago, has been named the new CEO. Robinson framed the move as a deliberate...
Daily Wire Names New CEO As Audience, Revenue Challenges Mount The Daily Wire announced Tuesday that CEO Caleb Robinson is stepping down effective immediately and transitioning to a board role while retaining significant ownership in the company. Mike Richards, who joined as President and Chief Content Officer roughly a year ago, has been named the new CEO. Robinson framed the move as a deliberate shift: "Stepping down as CEO of Daily Wire. Effective immediately, my new title is 'guy on the board who still owns a lot of the company.' Pay cut in stress. Raise in the important things." pic.twitter.com/3D0hpjn3nJ — Daily Wire (@realDailyWire) May 20, 2026 Earlier this month, Puck reported that The Daily Wire's audience is in freefall. Ben Shapiro's flagship show episodes, which once regularly drew several million viewers, now average around half a million. The company reportedly lost 80,000 YouTube subscribers in 2026 alone, described by analyst Kyle Tharp as "the steepest decline of any major political channel" this year. A few days later, New York Magazine highlighted other warning signs, including Daily Wire YouTube videos garnering fewer than 10,000 views days after posting (a sharp contrast to the channel's more than 3 million subscribers) and mocked comment sections. While acknowledging poor business decisions such as feature films, the Pendragon Cycle fantasy series, and unusual merchandise lines, Barkan argued the deeper issue is the "collapse of Shapiro’s constituency," particularly among young and Gen-Z conservatives who once drove the company's growth. In recent weeks the company carried out layoffs affecting a reported 42 employees - roughly 20 percent of headcount - concentrated at its Nashville production office. A Daily Wire source told Puck that the cuts were a "course correction after years of mismanagement and overhiring," while attributing part of the audience softening to platform algorithm changes that favor more partisan or conspiratorial content....
SuperBuzz ( SPZ:CA ) said on Thursday that Christopher Gulka has resigned as chief financial officer, effective May 15, 2026. The company has appointed Reem Chalhoub as its new CFO. SuperBuzz also said that it will move from quarterly to semi-annual financial reporting. Source: Press Release More on SuperBuzz Inc. Financial information for SuperBuzz Inc.
SuperBuzz ( SPZ:CA ) said on Thursday that Christopher Gulka has resigned as chief financial officer, effective May 15, 2026. The company has appointed Reem Chalhoub as its new CFO. SuperBuzz also said that it will move from quarterly to semi-annual financial reporting. Source: Press Release More on SuperBuzz Inc. Financial information for SuperBuzz Inc.
B Group disclosed a purchase of 750,000 shares of ADMA Biologics (NASDAQ:ADMA) in a May 15, 2026, SEC filing, an estimated $11.84 million trade based on quarterly average pricing. According to a May 15, 2026, SEC filing , B Group, Inc. increased its position in ADMA Biologics by 750,000 shares, with the estimated transaction value at $11.84 million based on the quarterly average price. The fund’s ...
B Group disclosed a purchase of 750,000 shares of ADMA Biologics (NASDAQ:ADMA) in a May 15, 2026, SEC filing, an estimated $11.84 million trade based on quarterly average pricing. According to a May 15, 2026, SEC filing , B Group, Inc. increased its position in ADMA Biologics by 750,000 shares, with the estimated transaction value at $11.84 million based on the quarterly average price. The fund’s holding at quarter’s end stood at 3,207,542 shares, worth $28.90 million. The net position change, including share additions and price fluctuations, was a decrease of $15.93 million over the quarter. ADMA Biologics, Inc. is a biopharmaceutical company specializing in plasma-derived therapies for immune deficiencies and infectious diseases. The company leverages a vertically integrated business model, controlling both plasma collection and product manufacturing to ensure supply chain reliability and product quality. With a focused portfolio and established distribution channels, ADMA Biologics addresses critical needs in the immunology and infectious disease markets, supporting its growth strategy and competitive positioning. Continue reading